Navigation Links
NCIIA Announces New Undergraduate Competition
Date:10/7/2009

PITTSBURGH, Oct. 7 /PRNewswire/ -- Today the National Collegiate Inventors and Innovators Alliance (NCIIA) announced the launch of BMEStart, an award recognizing undergraduate excellence in biomedical innovation. BMEStart stands apart from the NCIIA's other biomedical competition (BMEidea) because of its focus on younger inventors who do not have as much experience with product development.

The BMEStart competition welcomes submissions from undergraduate students at all NCIIA member colleges and universities. Each team must include at least one engineering student, but teams are encouraged to incorporate members from diverse fields such as business, law, medicine, life sciences and physical sciences or similar disciplines, as long as the ultimate submission solves a clinical problem. In alignment with the NCIIA's focus on helping student projects from concept to commercialization, submissions should also meet technical, economic, legal and regulatory requirements; feature novel and practical designs; and show potential for commercialization.

"This prize will allow undergraduate students the chance to shine on their own," said , Executive Director of the NCIIA. "But at the same time, we'll be judging teams by standards similar to graduate students, such as how feasible and eventually marketable their ideas are." The top team will be awarded a $10,000 grant to support further development of its product, with grants of $5,000 and $2,500 being rewarded to the second and third-place teams, respectively. Teams may register for the competition and submit their materials on-line here: http://www.nciia.org/competitions. Submissions open November 1.

BMEStart was announced at the annual BMEidea workshop, held this year in Pittsburgh. Recently home to the annual G-20 summit, Pittsburgh has seen an economic resurgence in recent years, ranking as the United States' most livable city in The Economist. Before the BMEStart prize announcement, Renal Solutions, Inc. (RSI) founder Peter DeComo, a Pittsburgh- area native, addressed attendees--biomedical engineering faculty from around the country--

about advancing the development of Life Science companies.

The BMEidea competition is sponsored by the NCIIA; the Industrial Design Society of America (IDSA); the National Science Foundation; and Boston Scientific; and is endorsed by the Biomedical Engineering Society (BMES) and the Council of Chairs of Bioengineering and Biomedical Engineering Programs.

About the NCIIA

The NCIIA achieves positive and sustainable social and environmental impact through technological innovation by providing end-to-end service grants, mentoring and other experiential resources to higher education institutions. With support from the Lemelson Foundation, the National Science Foundation and a membership of nearly 200 colleges and universities from all over the United States, the NCIIA engages more than 5,000 student entrepreneurs each year, leveraging their respective campuses as working laboratories and incubators for businesses and ultimately helping them to bring their concepts to commercialization. For more information, please visit http://www.nciia.org.

    Carrie Barnes
    ELISE communications
    215.239.4643
    carrie@elisecommunications.com

SOURCE NCIIA


'/>"/>
SOURCE NCIIA
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. NCIIA Honors Top Collegiate Biomedical Engineering Teams
2. The NCIIA Recognizes Collegiate Biomedical Engineering Innovations
3. NCIIA Announces Launch of 4th Annual Student Biomedical Innovation Competition
4. Sangamo Announces Pricing of Public Offering of Common Stock
5. Varian, Inc. Announces Stockholder Approval of Merger Agreement With Agilent Technologies
6. Verenium Announces Proposed Public Offering of Common Stock
7. Boston Scientific Announces Exclusive Sponsorship and First Enrollments of MADIT-RIT Clinical Trial
8. YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD., AN AUSTRALIAN CANCER-FOCUSED DEVELOPMENT COMPANY
9. ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema (MIVI II DME)
10. Oncothyreon announces appointment of Douglas E. Williams, Ph.D., to board of directors
11. Vermillion Announces Return of Eric Fung, M.D., Ph.D.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... Executive search firm, Slone ... Analytical Services. Harvill is a distinguished life sciences expert with a proven track ... leader in a wide range of services related to laboratory testing and analysis ...
(Date:3/27/2017)... Infectex Ltd., a Russian portfolio company of Maxwell Biotech Venture ... added to the standard drug therapy regimen in patients with multidrug-resistant pulmonary tuberculosis (MDR-TB). ... USA ) and the US National Institutes of Health. ... ... Logo ...
(Date:3/27/2017)... ... March 27, 2017 , ... A research team ... vascular grafts in JoVE’s Video Journal, the world’s first peer-reviewed scientific video journal. ... of treating coronary artery disease (CAD). Lam is an assistant professor at the ...
(Date:3/24/2017)... and ROCKVILLE, Md. , March ... of Maxwell Biotech Venture Fund (MBVF), today announced positive ... added to the standard drug therapy regimen in patients ... small molecule drug discovered by scientists at Sequella, Inc. ... Institutes of Health. A total of ...
Breaking Biology Technology:
(Date:3/6/2017)... SAN MATEO, Calif. , March 6, 2017 ... predictive marketing and sales technology, today announced Predictive ... (AI) solution for infusing actionable sales intelligence into ... customers to automatically enable their sales organizations with ... contextual messages that allow for intelligent engagement. Predictive ...
(Date:3/2/2017)... 2017 Summary This report provides ... KGaA and its partnering interests and activities since 2010. ... Description The Partnering Deals and Alliance since 2010 report ... one of the world,s leading life sciences companies. ... to ensure inclusion of the most up to date ...
(Date:3/2/2017)... Australia , March 2, 2017 Australian ... Ltd (ASX: CYP), has signed an agreement with ... from the Monash Biomedicine Discovery Institute and Department of ... to conduct a further preclinical study to support the ... treatment of asthma.  Asthma is a ...
Breaking Biology News(10 mins):